BioSig Technologies Announces New Collaboration on Development of Artificial Intelligence Solutions in Healthcare
03 déc. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Dec. 03, 2019 (GLOBE NEWSWIRE) -- ·The Company partners with Reified Capital, a provider of advanced artificial intelligence-focused technical advisory services to the private sector...
BioSig Technologies Signs Three New Licensing Agreements with Mayo Clinic
26 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 26, 2019 (GLOBE NEWSWIRE) -- ·New areas of collaboration identified between Mayo Clinic and BioSig ·Focus on previously untapped arrhythmia treatments ...
BioSig Commences Clinical Trial Enrollment for PURE EP System
21 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 21, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance
18 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 18, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
BioSig Technologies Issues November 2019 Shareholder Letter
14 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 14, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
BioSig Technologies Invests in Union College’s Internship Program
07 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 07, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
Sasha Gentling, CFA Joins BioSig as Director of Business Development
06 nov. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Nov. 06, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patients at American College of Rheumatology (ACR) Annual Meeting 2019
29 oct. 2019 09h00 HE
|
SetPoint Medical
VALENCIA, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results...
BioSig Appoints Andrew Ballou as Vice President of Investor Relations
29 oct. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 29, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
BioSig Opens a Technology Development Office in Rochester, MN
15 oct. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, Oct. 15, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...